Clinical and economic impact of molecular testing for BRAF fusion in pediatric low-grade Glioma

• Prif Awduron: Juan David Rios (Awdur), Russanthy Velummailum (Awdur), Julie Bennett (Awdur), Liana Nobre (Awdur), Derek S. Tsang (Awdur), Eric Bouffet (Awdur), Cynthia Hawkins (Awdur), Uri Tabori (Awdur), Avram Denburg (Awdur), Petros Pechlivanoglou (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: BMC, 2022-01-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Abstract Background Treatment personalization via tumor molecular testing holds promise for improving outcomes for patients with pediatric low-grade glioma (PLGG). We evaluate the health economic impact of employing tumor molecular testing to guide treatment for patients diagnosed with PLGG, particu...